Cargando…
[(18)F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review
The aim of this systematic review is to provide a comprehensive overview of the role of fluoro-5α-dihydrotestosterone ([(18)F]-FDHT) for the in vivo imaging of androgen receptors (AR) through positron emission tomography (PET) in metastatic breast (mBC) and metastatic castration-resistant prostate c...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417772/ https://www.ncbi.nlm.nih.gov/pubmed/37568977 http://dx.doi.org/10.3390/diagnostics13152613 |
_version_ | 1785088118667345920 |
---|---|
author | Filippi, Luca Urso, Luca Schillaci, Orazio Evangelista, Laura |
author_facet | Filippi, Luca Urso, Luca Schillaci, Orazio Evangelista, Laura |
author_sort | Filippi, Luca |
collection | PubMed |
description | The aim of this systematic review is to provide a comprehensive overview of the role of fluoro-5α-dihydrotestosterone ([(18)F]-FDHT) for the in vivo imaging of androgen receptors (AR) through positron emission tomography (PET) in metastatic breast (mBC) and metastatic castration-resistant prostate cancer (mCRPC). Relevant studies published from 2013 up to May 2023 were selected by searching Scopus, PubMed and Web of Science. The selected imaging studies were analyzed using a modified version of the critical Appraisal Skills Programme (CASP). Eleven studies encompassing 321 patients were selected. Seven of the eleven selected papers included 266 subjects (82.2%) affected by mCRPC, while four encompassed 55 (17.2%) patients affected by mBC. [(18)F]-FDHT PET showed a satisfying test/retest reproducibility, and when compared to a histochemical analysis, it provided encouraging results for in vivo AR quantification both in mCRPC and mBC. [(18)F]-FDHT PET had a prognostic relevance in mCRPC patients submitted to AR-targeted therapy, while a clear association between [(18)F]-FDHT uptake and the bicalutamide response was not observed in women affected by AR-positive mBC. Further studies are needed to better define the role of [(18)F]-FDHT PET, alone or in combination with other tracers (i.e., [(18)F]-FDG/[(18)F]-FES), for patients’ selection and monitoring during AR-targeted therapy, especially in the case of mBC. |
format | Online Article Text |
id | pubmed-10417772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104177722023-08-12 [(18)F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review Filippi, Luca Urso, Luca Schillaci, Orazio Evangelista, Laura Diagnostics (Basel) Systematic Review The aim of this systematic review is to provide a comprehensive overview of the role of fluoro-5α-dihydrotestosterone ([(18)F]-FDHT) for the in vivo imaging of androgen receptors (AR) through positron emission tomography (PET) in metastatic breast (mBC) and metastatic castration-resistant prostate cancer (mCRPC). Relevant studies published from 2013 up to May 2023 were selected by searching Scopus, PubMed and Web of Science. The selected imaging studies were analyzed using a modified version of the critical Appraisal Skills Programme (CASP). Eleven studies encompassing 321 patients were selected. Seven of the eleven selected papers included 266 subjects (82.2%) affected by mCRPC, while four encompassed 55 (17.2%) patients affected by mBC. [(18)F]-FDHT PET showed a satisfying test/retest reproducibility, and when compared to a histochemical analysis, it provided encouraging results for in vivo AR quantification both in mCRPC and mBC. [(18)F]-FDHT PET had a prognostic relevance in mCRPC patients submitted to AR-targeted therapy, while a clear association between [(18)F]-FDHT uptake and the bicalutamide response was not observed in women affected by AR-positive mBC. Further studies are needed to better define the role of [(18)F]-FDHT PET, alone or in combination with other tracers (i.e., [(18)F]-FDG/[(18)F]-FES), for patients’ selection and monitoring during AR-targeted therapy, especially in the case of mBC. MDPI 2023-08-07 /pmc/articles/PMC10417772/ /pubmed/37568977 http://dx.doi.org/10.3390/diagnostics13152613 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Filippi, Luca Urso, Luca Schillaci, Orazio Evangelista, Laura [(18)F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review |
title | [(18)F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review |
title_full | [(18)F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review |
title_fullStr | [(18)F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review |
title_full_unstemmed | [(18)F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review |
title_short | [(18)F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review |
title_sort | [(18)f]-fdht pet for the imaging of androgen receptor in prostate and breast cancer: a systematic review |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417772/ https://www.ncbi.nlm.nih.gov/pubmed/37568977 http://dx.doi.org/10.3390/diagnostics13152613 |
work_keys_str_mv | AT filippiluca 18ffdhtpetfortheimagingofandrogenreceptorinprostateandbreastcancerasystematicreview AT ursoluca 18ffdhtpetfortheimagingofandrogenreceptorinprostateandbreastcancerasystematicreview AT schillaciorazio 18ffdhtpetfortheimagingofandrogenreceptorinprostateandbreastcancerasystematicreview AT evangelistalaura 18ffdhtpetfortheimagingofandrogenreceptorinprostateandbreastcancerasystematicreview |